Resonant Medical's radiation therapy guiding platform:
This article was originally published in Clinica
Executive Summary
Resonant Medical's Restitu system is a 3D ultrasound image-guided radiation therapy platform. Tumour position verification for patient realignment is crucial in the radiotherapy of many cancers, given that organs are prone to change shape and shift their internal position from one treatment day to the next, said the Montreal, Quebec-based firm. Restitu quantifies these changes in organ position and morphology, allowing doctors to achieve accurate patient positioning during external beam radiation therapy.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.